| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14157221 | 2014-02-28 | ||
| PCT/EP2015/053725WO2015128287A1 (en) | 2014-02-28 | 2015-02-23 | Pcsk9 vaccines |
| Publication Number | Publication Date |
|---|---|
| SG11201606685XAtrue SG11201606685XA (en) | 2016-09-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201606685XASG11201606685XA (en) | 2014-02-28 | 2015-02-23 | Pcsk9 vaccines |
| Country | Link |
|---|---|
| US (1) | US10004791B2 (en) |
| EP (1) | EP3110439B1 (en) |
| JP (1) | JP6494667B2 (en) |
| KR (1) | KR102360250B1 (en) |
| CN (1) | CN106459209B (en) |
| AU (1) | AU2015222283B2 (en) |
| BR (1) | BR112016019389A8 (en) |
| CA (1) | CA2940315C (en) |
| DK (1) | DK3110439T3 (en) |
| ES (1) | ES2732741T3 (en) |
| IL (1) | IL247159B (en) |
| MX (1) | MX374276B (en) |
| PL (1) | PL3110439T3 (en) |
| RU (1) | RU2698971C2 (en) |
| SG (1) | SG11201606685XA (en) |
| WO (1) | WO2015128287A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102857456B1 (en) | 2015-11-03 | 2025-09-08 | 에이씨 이뮨 에스에이 | Methods for immunization against autoantigens in human patients |
| JP2019509714A (en)* | 2016-01-05 | 2019-04-11 | ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． | PCSK9 antibody, antigen binding fragment thereof and pharmaceutical use |
| ES2571055B1 (en)* | 2016-02-15 | 2016-12-28 | Araclon Biotech, S.L. | Amyloid conjugate and its uses and procedures |
| CN106822881A (en)* | 2016-12-09 | 2017-06-13 | 四川大学 | A kind of hyperlipoproteinemia vaccine for PCSK9 |
| US11325945B2 (en) | 2017-04-12 | 2022-05-10 | Cadila Healthcare Limited | Peptide based PCSK9 vaccine |
| US20240299510A1 (en)* | 2020-12-31 | 2024-09-12 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins |
| JP2025508948A (en) | 2022-02-28 | 2025-04-10 | トライデム バイオサイエンス ゲーエムベーハー ウント コンパニー カーゲー | Conjugates consisting of or including at least β-glucan or mannan |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011027257A2 (en)* | 2009-09-03 | 2011-03-10 | Pfizer Vaccines Llc | Pcsk9 vaccine |
| EP2493507A4 (en)* | 2009-10-30 | 2013-11-20 | Merck Sharp & Dohme | ANTAGONISTS AND VARIANTS AX213 AND AX132 PCSK9 |
| AU2010313381A1 (en) | 2009-10-30 | 2012-04-12 | Merck Sharp & Dohme Corp. | AX1 and AX189 PCSK9 antagonists and variants |
| GB201005005D0 (en)* | 2010-03-25 | 2010-05-12 | Angeletti P Ist Richerche Bio | New vaccine |
| DK2570135T3 (en)* | 2011-09-13 | 2016-02-15 | Affiris Ag | PCSK9-Vaccine |
| WO2013148284A1 (en) | 2012-03-29 | 2013-10-03 | Genentech, Inc. | Antibodies that bind to a pcsk9 cleavage site and methods of use |
| Publication number | Publication date |
|---|---|
| RU2016138365A (en) | 2018-03-29 |
| KR102360250B1 (en) | 2022-02-07 |
| JP2017508006A (en) | 2017-03-23 |
| US10004791B2 (en) | 2018-06-26 |
| JP6494667B2 (en) | 2019-04-03 |
| CA2940315C (en) | 2022-08-23 |
| BR112016019389A8 (en) | 2022-11-08 |
| IL247159B (en) | 2018-01-31 |
| EP3110439B1 (en) | 2019-03-27 |
| MX374276B (en) | 2025-03-06 |
| RU2698971C2 (en) | 2019-09-02 |
| WO2015128287A1 (en) | 2015-09-03 |
| CA2940315A1 (en) | 2015-09-03 |
| US20170065689A1 (en) | 2017-03-09 |
| BR112016019389A2 (en) | 2017-10-24 |
| DK3110439T3 (en) | 2019-05-13 |
| ES2732741T3 (en) | 2019-11-25 |
| RU2016138365A3 (en) | 2018-08-20 |
| KR20160124901A (en) | 2016-10-28 |
| MX2016010838A (en) | 2016-11-17 |
| NZ722918A (en) | 2022-03-25 |
| EP3110439A1 (en) | 2017-01-04 |
| AU2015222283B2 (en) | 2019-11-21 |
| CN106459209B (en) | 2019-10-11 |
| PL3110439T3 (en) | 2019-09-30 |
| CN106459209A (en) | 2017-02-22 |
| AU2015222283A1 (en) | 2016-09-08 |
| Publication | Publication Date | Title |
|---|---|---|
| GB201410971D0 (en) | Vaccine | |
| GB2528701B (en) | Pillow | |
| GB201518684D0 (en) | Vaccine | |
| GB2536850B (en) | Pillow | |
| PL3185899T3 (en) | Improved hvt-vectored nd-ibd vaccine | |
| GB201413086D0 (en) | Methods | |
| SG11201610946YA (en) | Meningococcus vaccines | |
| IL247159B (en) | Pcsk9 vaccines | |
| GB201522132D0 (en) | Vaccine | |
| GB201416727D0 (en) | Use | |
| GB201416716D0 (en) | Use | |
| GB201608821D0 (en) | Vaccines | |
| GB201408745D0 (en) | Methods | |
| SMT202000589T1 (en) | Vaccine | |
| DK3145380T3 (en) | Toiletventilationssystem | |
| GB201402083D0 (en) | Retaining means | |
| GB201417214D0 (en) | Vaccine | |
| GB2522661B (en) | Context configuration | |
| GB201415685D0 (en) | Methods | |
| HUP1400095A2 (en) | Safe crosswalk with speedbreakers | |
| GB201614387D0 (en) | Improved vaccines | |
| GB201518917D0 (en) | Vaccination | |
| GB201406628D0 (en) | Vaccine | |
| GB201503266D0 (en) | Vaccination | |
| GB201414122D0 (en) | Methods |